IBEX 35
10.942,40 -49,90 (-0,45%) Euro Stoxx 50
4.867,41 +28,27 (+0,58%) Dólar/Euro
1,0723 +0,0014 (+0,13%) Petróleo Brent
82,85 +0,23 (+0,28%) Oro
2.338,00 -11,10 (-0,47%) Bitcoin EUR
61.207,16 -920,50 (-1,48%)
Kindstar Globalgene Technology, Inc. (9960.HK)
Kindstar Globalgene Technology, Inc.
Biolake D2-1
666 Gaoxin Road East Lake High Tech Zone
Wuhan
China
86 40 0736 1666
https://www.kindstar.com.cn/en/
Sector(es): Healthcare
Sector: Diagnostics & Research
Empleados a tiempo completo: 3125
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Dr. Shiang Huang | Founder, Executive Chairman, CEO & Chief Medical Officer | 887,95k | N/A | 1959 |
| Mr. Zanbing Tu M.B.A. | Co-Founder, Executive Director & COO | 837,4k | N/A | 1972 |
| Ms. Haijie Chai | Executive Director, CFO & Joint Company Secretary | 757,18k | N/A | 1979 |
| Ms. Mei Yi Lee ACIS, ACS, FCIS, FCS | Joint Company Secretary | N/A | N/A | 1968 |
Descripción
Kindstar Globalgene Technology, Inc., an investment holding company, provides clinical testing services in the People's Republic of China. The company offers its esoteric testing services for hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology diseases. It also provides testing services for the early warning, prevention, diagnosis, selection of therapeutic schedules, and evaluation for curative effect of specialized diseases. The company's lab platforms comprise flow cytometry, cytogenetic, medical genomics, molecular biology, hematopathology, mass spectrum, pathology, clinical immunology, microbiology, and scientific research testing laboratories. Kindstar Globalgene Technology, Inc. was founded in 2003 and is headquartered in Wuhan, the People's Republic of China.
Gobierno corporativo
El ISS Governance QualityScore de Kindstar Globalgene Technology, Inc., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.
